228 related articles for article (PubMed ID: 24696463)
1. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
Wen B; Roongta V; Liu L; Moore DJ
Drug Metab Dispos; 2014 Jun; 42(6):1044-54. PubMed ID: 24696463
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
Wen B; Chen Y; Fitch WL
Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract.
Iwata H; Tezuka Y; Kadota S; Hiratsuka A; Watabe T
Drug Metab Pharmacokinet; 2005 Feb; 20(1):34-45. PubMed ID: 15770073
[TBL] [Abstract][Full Text] [Related]
4. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
5. The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: possible involvement of vanilloid receptors.
Kobayashi Y; Hoshikuma K; Nakano Y; Yokoo Y; Kamiya T
Planta Med; 2001 Apr; 67(3):244-8. PubMed ID: 11345696
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
Kang P; Dalvie D; Smith E; Zhou S; Deese A
Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
[TBL] [Abstract][Full Text] [Related]
7. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.
Wen B; Ma L; Zhu M
Chem Biol Interact; 2008 May; 173(1):59-67. PubMed ID: 18359012
[TBL] [Abstract][Full Text] [Related]
8. Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation.
Heo SK; Yun HJ; Yi HS; Noh EK; Park SD
J Cell Biochem; 2009 May; 107(1):123-33. PubMed ID: 19241441
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of a novel 3-substituted indole-containing TNF-alpha inhibitor: dehydrogenation and inactivation of CYP3A4.
Sun H; Yost GS
Chem Res Toxicol; 2008 Feb; 21(2):374-85. PubMed ID: 18095656
[TBL] [Abstract][Full Text] [Related]
10. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
11. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s.
Lee SK; Kim NH; Lee J; Kim DH; Lee ES; Choi HG; Chang HW; Jahng Y; Jeong TC
Planta Med; 2004 Aug; 70(8):753-7. PubMed ID: 15326550
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the in vitro metabolism of evodiamine: characterization of metabolites and involved cytochrome p450 isoforms.
Sun HZ; Fang ZZ; Cao YF; Sun XY; Hong M
Phytother Res; 2013 May; 27(5):705-12. PubMed ID: 22767428
[TBL] [Abstract][Full Text] [Related]
13. Zafirlukast metabolism by cytochrome P450 3A4 produces an electrophilic alpha,beta-unsaturated iminium species that results in the selective mechanism-based inactivation of the enzyme.
Kassahun K; Skordos K; McIntosh I; Slaughter D; Doss GA; Baillie TA; Yost GS
Chem Res Toxicol; 2005 Sep; 18(9):1427-37. PubMed ID: 16167835
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa.
Ueng YF; Wang JJ; Lin LC; Park SS; Chen CF
Life Sci; 2001 Nov; 70(2):207-17. PubMed ID: 11787945
[TBL] [Abstract][Full Text] [Related]
15. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice.
Ueng YF; Ko HC; Chen CF; Wang JJ; Chen KT
Life Sci; 2002 Aug; 71(11):1267-77. PubMed ID: 12106592
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation of glafenine by human liver microsomes and peroxidases: identification of electrophilic iminoquinone species and GSH conjugates.
Wen B; Moore DJ
Drug Metab Dispos; 2011 Sep; 39(9):1511-21. PubMed ID: 21628497
[TBL] [Abstract][Full Text] [Related]
17. Progress in Studies on Rutaecarpine. II.--Synthesis and Structure-Biological Activity Relationships.
Son JK; Chang HW; Jahng Y
Molecules; 2015 Jun; 20(6):10800-21. PubMed ID: 26111170
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of rutaecarpine.
Lee SK; Lee JH; Yoo HH; Kim DH; Jahng Y; Jeong TC
J Pharm Biomed Anal; 2006 Apr; 41(1):304-9. PubMed ID: 16318905
[TBL] [Abstract][Full Text] [Related]
19. [Determination of evodiamine and rutaecarpine in Evodia rutaecarpa (Juss.) Benth after compatibility with Coptis chinensis Franch].
Xu YC; Wei LX; Zhou YX; Wang YL
Zhongguo Zhong Yao Za Zhi; 2001 Dec; 26(12):846-7. PubMed ID: 12776335
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine.
Zhang FL; He X; Zhai YR; He LN; Zhang SC; Wang LL; Yang AH; An LJ
Xenobiotica; 2015; 45(11):978-89. PubMed ID: 26053557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
